BPC-157 vs TB-500
Compare BPC-157, TB-500: half-life, time to Cmax, dosing interval, published dose ranges and titration — citation-backed, research use only.
| BPC-157Body Protection Compound 157View BPC-157 → | TB-500Thymosin Beta-4 fragmentView TB-500 → | |
|---|---|---|
| Class | Healing / Repair | Healing / Repair |
| Route | Subcutaneous | Subcutaneous |
| Plasma half-life | 4 h | 6 h |
| Time to Cmax | 1 h | 2 h |
| Typical interval | Once daily | Once weekly |
| Published dose range | 0.25–0.5 mg | 2–10 mg |
| Titration ladder | No preset ladder | No preset ladder |
| Summary | Synthetic pentadecapeptide derived from human gastric juice protein. Studied for tissue repair. | Synthetic fragment of thymosin beta-4. Studied for soft-tissue and connective-tissue recovery. |
Source references
BPC-157
- Sikiric P et al., Curr Pharm Des 16:1224 (peripheral t½ short, local effects prolonged) (2010)
- Chang CH et al., J Appl Physiol 110:774 (2011)
TB-500
- Goldstein AL et al., Ann N Y Acad Sci 1269:1 (2012)
- Crockford D et al., Ann N Y Acad Sci 1194:179 (2010)
For research use only. Not for human consumption. This tracker visualises only the doses you have logged or scheduled — it does not recommend dose sizes, does not suggest what to take, and is not pharmacokinetically calibrated. It is not medical advice and does not diagnose, treat, cure, or prevent any condition. Consult a licensed clinician before making any medical decision.